Literature DB >> 7321020

Value of anticoagulants in treatment of pulmonary embolism.

P Egermayer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7321020      PMCID: PMC1439483          DOI: 10.1177/014107688107401225

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  5 in total

1.  Management of heparin therapy: Controlled prospective trial.

Authors:  E W Salzman; D Deykin; R M Shapiro; R Rosenberg
Journal:  N Engl J Med       Date:  1975-05-15       Impact factor: 91.245

2.  Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial.

Authors:  D W BARRITT; S C JORDAN
Journal:  Lancet       Date:  1960-06-18       Impact factor: 79.321

3.  A critique of methodology in studies of anticoagulant therapy for acute myocardial infarction.

Authors:  R H Gifford; A R Feinstein
Journal:  N Engl J Med       Date:  1969-02-13       Impact factor: 91.245

4.  Factors contributing to the incorrect diagnosis of pulmonary embolic disease.

Authors:  B Modan; E Sharon; N Jelin
Journal:  Chest       Date:  1972-10       Impact factor: 9.410

5.  Accuracy of the clinical diagnosis of pulmonary embolism.

Authors:  F J Hildner; R S Ormond
Journal:  JAMA       Date:  1967-11-13       Impact factor: 56.272

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.